Page last updated: 2024-10-27

fomepizole and Hospital-Acquired Condition

fomepizole has been researched along with Hospital-Acquired Condition in 1 studies

Fomepizole: A pyrazole and competitive inhibitor of ALCOHOL DEHYDROGENASE that is used for the treatment of poisoning by ETHYLENE GLYCOL or METHANOL.
fomepizole : A member of the class of pyrazoles that is 1H-pyrazole substituted by a methyl group at position 4.

Research Excerpts

ExcerptRelevanceReference
"The methanol level was 13 mg/dL 3 h after fomepizole treatment and even lower thereafter; therefore, no additional fomepizole was required."1.91A Case of an Intraoperative Iatrogenic Methanol Exposure. ( Akpunonu, P; Johnson, E; Kalani, M; Maskey, A; McCoy, A; Mefford, B; Micciche, A, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Micciche, A1
Johnson, E1
Mefford, B1
McCoy, A1
Akpunonu, P1
Kalani, M1
Maskey, A1

Other Studies

1 other study available for fomepizole and Hospital-Acquired Condition

ArticleYear
A Case of an Intraoperative Iatrogenic Methanol Exposure.
    The American journal of case reports, 2023, Jul-18, Volume: 24

    Topics: Aged; Antidotes; Dimercaprol; Female; Fomepizole; Humans; Iatrogenic Disease; Methanol; Pyrazoles

2023